Back | Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
$NBIO .18's super thin on the ask! | budfoxfun | investorshub | 12/20/2022 4:38:04 PM |
Agreed. $NBIO trading just over a third | BlazingStocks | investorshub | 12/20/2022 4:17:46 PM |
$NBIO solid experience here! Dr. Babic has held | budfoxfun | investorshub | 12/20/2022 1:35:58 PM |
Wow! Nice pickup for the company! 2023 is | pumpnass | investorshub | 12/20/2022 1:34:01 PM |
$NBIO News December 20, 2022 Nascent Biotech Announces Appointment | BlazingStocks | investorshub | 12/20/2022 1:15:34 PM |
$NBIO News Out! Nascent Biotech Announces Appointment of | budfoxfun | investorshub | 12/20/2022 1:06:15 PM |
A little bit of volume... UP over 2% | BlazingStocks | investorshub | 11/30/2022 8:20:35 PM |
$NBIO - This issuance strengthens our growing IP | BlazingStocks | investorshub | 11/30/2022 7:21:15 PM |
Agreed, bidding but no takers. $NBIO | BlazingStocks | investorshub | 11/30/2022 4:35:29 PM |
$NBIO agree, time to load up! | budfoxfun | investorshub | 11/30/2022 4:32:01 PM |
$NBIO, this is huge - By March 2021, | BlazingStocks | investorshub | 11/30/2022 4:23:44 PM |
$NBIO thin to .30's! | budfoxfun | investorshub | 11/30/2022 3:19:17 PM |
$NBIO is certainly early-stage: its flagship drug is | budfoxfun | investorshub | 11/30/2022 2:14:31 PM |
$NBIO News November 30, 2022 Fishing for Bargains Nascent | BlazingStocks | investorshub | 11/30/2022 2:07:02 PM |
BOOOOOOOOOOOOM!!!!! | pumpnass | investorshub | 11/15/2022 8:59:22 PM |
Agreed... Glad I didn't sell this dip. $NBIO | BlazingStocks | investorshub | 11/15/2022 8:49:37 PM |
No doubt bro! Looks like the bottom is | pumpnass | investorshub | 11/15/2022 8:44:22 PM |
It's certainly possible. $NBIO trading 40% over its | BlazingStocks | investorshub | 11/15/2022 8:39:25 PM |
whytestocks: $NBIO News Article - Nascent Biotech Inc (OTCMKTS:NBIO) Continues to Build a Strong Cas | whytestocks | investorshangout | 11/15/2022 8:35:58 PM |
whytestocks: $NBIO News Article - Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for | whytestocks | investorshangout | 09/13/2022 12:30:50 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...